SignalMacro

JAPAN STEM CELL HEART DISEASE PATCH GETS INSURANCE APPROVAL - NIKKEI

Insurance approval is a major catalyst for Japan's stem cell heart disease patch.

What changed

Insurance approval is a major catalyst for Japan's stem cell heart disease patch.

Why it matters

Insurance approval is a major catalyst for Japan's stem cell heart disease patch. — impact context not separately stored; see What changed.

Sources